Zydus Wellness appoints Adhir Anand as Head of Media & Digital
Former Wavemaker executive to lead media strategy and digital transformation agenda
Former Wavemaker executive to lead media strategy and digital transformation agenda
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
Indian companies must make their own intermediates and support small industries: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
TROPION-Lung01, evaluating AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan versus chemotherapy, previously met the dual primary endpoint of progression-free survival in the overall trial population
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Subscribe To Our Newsletter & Stay Updated